Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021

Abstract

Objetivo: Colombia diseñó y adoptó un plan de vacunación contra COVID-19. El objetivo de esta investigación fue conocer su disposición para aceptar la vacunación contra COVID-19 en personas de 80 y más años. Métodos: Se realizó una encuesta telefónica a 11.721 personas de 80 y más años, afiliados a una aseguradora de salud en la que se indagó sobre la disponibilidad a recibir la vacuna. Los respondientes fueron los afiliados o sus familiares o cuidadores. Resultados. El promedio de edad fue 85,0 años (DE: 4,5), sin diferencias entre sexos. 3.344 participantes (28,5%) refirieron el antecedente de haberse realizado una prueba diagnóstica previa de COVID-19 y 73 resultaron positivos. La incidencia acumulada de infección por Covid-19, desde marzo 2020, fue de 622,8 por 100 mil personas (IC95% 491-778 por 100.000). Respecto a la actitud hacia la vacunación contra COVID-19, uno de cada cuatro respondientes se abstuvo de opinar o se manifestó neutro. Cuando el respondiente era un familiar, la aceptación de la vacuna era de 60,4% (IC95% 59,5 - 61,3) con diferencias por sexo: entre los hombres era 62,2% (IC95%: 60,8 - 63,6) y en mujeres del 59,2 (IC95%: 58,0 - 60,3) p<0.05. Cuando el respondiente fue el potencial receptor de la vacuna, la aceptación de la vacuna fue de 61,7% (IC95% 59,4 - 64,0) y también difería por sexos: 70,2% en hombres (IC95%: 66,9 - 73,5) y 55,1% en mujeres (IC95%: 52,0 - 58,3) p<0.05. Conclusión. La relativamente baja aceptación de la vacunación contra COVID-19 en Colombia plantea retos importantes para lograr el control de la pandemia.

Acceptance towards COVID-19 vaccination in Latin America and the Caribbean: A systematic review and meta-analysis

“…After the elimination of duplicate studies, we assessed the titles and abstracts of the 434 remaining studies, and 401 articles were eliminated because they did not match the selection criteria. A total of 33 studies were read in full-text and 19 studies were included in the qualitative synthesis and 18 in the quantitative synthesis [ 10 , 13 , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] ]. We did not include the study of Villareal-Garza et al in the meta-analysis of non-pregnant women, because the study population was specifically women with breast cancer whereas the population of the remaining articles was made up of individuals without a specific pathology.…”

Care for dementia patients and caregivers and COVID-19 pandemic: Correspondence

“…We have reached the stage of the COVID-19 pandemic that encouraging mass COVID vaccination is very important, yet, there is reluctance in certain regions among the older people and their caregivers of receiving vaccination, in fear of the side effects. For example, a recent report from Colombia showed that only one-sixth of the caregivers of the elderly gave an opinion on acceptance of COVID-19 vaccination [4] . Hence passing on the right information about the benefit of vaccination is very important as well.…”

How Possible Is the Elimination of Viral Hepatitis? An Analysis Based on the Global Burden of Disease from Hepatitis B and C, 1990–2019

“…By the end of the 19th century and the beginning of the 20th, the discoveries of microorganisms that cause specific diseases (tuberculosis, cholera, diphtheria, tetanus, pneumonia, meningitis, syphilis, and others) and the identification of vectors capable of transmitting diseases (the Anopheles mosquito for malaria) [2] consolidated a new paradigm for the study of infectious diseases, their control and prevention [3]. In addition, with the development of vaccines and the emergence of antimicrobial therapy during the first half of the 20th century, we were excited about the disappearance of infectious diseases [4]. At least, that was the perception that high-income countries had during the 1960s and 1970s, especially inspired by the eradication of smallpox [5] and which, in some way, motivated the theory of epidemiological transition [6].…”